Nutex Health, Inc. (NUTX) Stock Overview
Explore Nutex Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Nutex Health, Inc. (NUTX)
Key Financials
Key Financials
Market Cap
868.6M
P/E Ratio
10.93
EPS (TTM)
$12.94
ROE
0.31%
NUTX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Nutex Health, Inc. (NASDAQ: NUTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Nutex Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NUTX on the NASDAQ shows an RSI of 44.43, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $122.55 for the NASDAQ listing.
Key metrics behind Nutex Health, Inc.'s NASDAQ-traded stock include a P/E ratio of 10.93 and a market capitalization of 868.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NUTX on the NASDAQ.